Evidence map›Paper›PMID 41039499›Full record

ArticleCell communication and signaling : CCS2025

A comparative proteomic, transcriptomic and glycomic analysis of extracellular vesicle isolation techniques highlights ExoGAG efficiency for a more complete identification of breast milk molecular signaling pathways.

María Pereira-Hernández, Rosaura Picáns-Leis, María E Vázquez-Mosquera, Nerea Lago-Baameiro, Pedro Fortes-González, Laura López-Valverde, Ana Barcia de la Iglesia, Laura Núñez-González, Susana B Bravo, María Pardo and 2 more

Abstract readComparative Study
In one paragraph

Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

María Pereira-Hernández *Group of Genetics and Developmental Biology of Renal Disease, Laboratory of Nephrology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital (CHUS), Santiago de Compostela, 15706, Spain.ORCID http://orcid.org/0000-0002-0671-7470
Rosaura Picáns-Leis *Neonatology Department. Metabolic Unit, RICORS-SAMID, CIBERER. University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, 15706, Spain.ORCID http://orcid.org/0000-0003-4702-9962
María E Vázquez-Mosquera *Neonatology Department. Metabolic Unit, RICORS-SAMID, CIBERER. University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, 15706, Spain.ORCID http://orcid.org/0000-0003-3167-5919
Nerea Lago-BaameiroObesidomic Group, Endocrinology Area, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital (CHUS)/SERGAS, Santiago de Compostela, 15706, Spain.ORCID http://orcid.org/0000-0003-1257-4856
Pedro Fortes-GonzálezGroup of Genetics and Developmental Biology of Renal Disease, Laboratory of Nephrology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital (CHUS), Santiago de Compostela, 15706, Spain.ORCID http://orcid.org/0009-0008-7016-0292
Laura López-ValverdeNeonatology Department. Metabolic Unit, RICORS-SAMID, CIBERER. University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, 15706, Spain.ORCID http://orcid.org/0000-0003-2504-6008
Ana Barcia de la IglesiaGroup of Genetics and Developmental Biology of Renal Disease, Laboratory of Nephrology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital (CHUS), Santiago de Compostela, 15706, Spain.ORCID http://orcid.org/0000-0003-1484-5656
Laura Núñez-GonzálezGroup of Genetics and Developmental Biology of Renal Disease, Laboratory of Nephrology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital (CHUS), Santiago de Compostela, 15706, Spain.ORCID http://orcid.org/0000-0001-5656-7223
Susana B BravoProteomic Platform, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital (CHUS), Santiago de Compostela, 15706, Spain.ORCID http://orcid.org/0000-0001-7615-3079
María PardoObesidomic Group, Endocrinology Area, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital (CHUS)/SERGAS, Santiago de Compostela, 15706, Spain.ORCID http://orcid.org/0000-0002-9967-1650
María L CouceNeonatology Department. Metabolic Unit, RICORS-SAMID, CIBERER. University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, 15706, Spain. maria.luz.couce.pico@sergas.es.ORCID http://orcid.org/0000-0003-4861-9905
Miguel A Garcia-GonzalezGroup of Genetics and Developmental Biology of Renal Disease, Laboratory of Nephrology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital (CHUS), Santiago de Compostela, 15706, Spain. miguel.garcia.gonzalez@sergas.es.ORCID http://orcid.org/0000-0002-4330-7200

Funding

Instituto de Salud Carlos III (ISCIII) PI15/01467Instituto de Salud Carlos III (ISCIII) PI22/00227Instituto de Salud Carlos III (ISCIII) RICORS program to RICORS2040 RD21/0005/0020Senefro foundation SEN2021_2Xunta de Galicia/GAIN , Grupos con potencial de crecemento IN607B2023/07
6 · The paper itself

Abstract

backgroundHuman milk (HM) is the first form of communication between mothers and newborns and it is implicated in the infant growth and protection. We recently showed a functional characterization of HM, unmasking the molecular mechanisms related to EVs signaling and its functional role in prematurity. In that study, we identified the need to establish and optimize a standard isolation protocol for human milk extracellular vesicles (mEVs).

methodsFour mEVs isolation methods were compared: ultracentrifugation (UC), size exclusion chromatography (SEC), immunoprecipitation with tetraspanin CD9 (IP_CD9) and ExoGAG. Three pools of human milk (each composed of samples from ten donor mothers) were used and isolation of mEVs was performed starting from the same volume for each method. The proteomic, transcriptomic and glycomic composition of the extracellular vesicles obtained after isolation was then analyzed for each method. The sensitivity, specificity and quality of the results were also determined. A comparative analysis of results common across all isolation methods was performed to identify potential signaling pathways associated with mEVs.

resultsExoGAG and UC proved to be the most efficient of the four techniques compared for mEVs isolation. However, ExoGAG compared to UC provided a higher concentration of total and vesicle-related proteins and peptides and a higher glycoprotein count keeping all the glycan subgroups. Despite ExoGAG and UC show similar vesicle profiles in terms of size, concentration, tetraspanin subpopulations and EVs markers, ExoGAG was the most efficient technique in terms of accuracy, consistency and reproducibility for omics studies. Furthermore, results allowed us to identify that mEVs components are involved in the signaling pathways of infant biological development, immune system maturation and protein metabolism.

conclusionsThis study establishes UC and ExoGAG as reliable methods for mEVs isolation and describes its protocol, being ExoGAG the most efficient. Also, the omics analysis show that biomolecules conforming those mEVs are linked to the defense system against external agents (specific role in the immune system pathway) and in the correct establishment of the neural structure (developmental pathway), while providing all the nutritional requirements for the correct growth of the newborn (metabolic pathway).

Indexed as

Extracellular VesiclesGlycomicsMilk, HumanProteomicsSignal TransductionTranscriptomeFemaleHumansExtracellular vesiclesGlycomicsHuman milkIsolation methodProteomicsTranscriptomics

Identifiers

PMID41039499
PMCPMC12492545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.